Advisory Board and Editors Molecular Biology
Marisa Fabiana Nicolás
Dr. Marisa Fabiana Nicolás is a biologist with a Ph.D. in Genetics. She worked as a protein annotator in the UniProt/Swiss-Prot database from 2005 to 2007. Since May 2009 she is an Associate Researcher at the Bioinformatics Laboratory (Labinfo) at LNCC/MCTI Brazil. Dr. Nicolas has experience in Genetics, Molecular Biology, Genomics, and Bioinformatics. She works mainly in Bioinformatics applied to the analysis of genomes and transcriptomes (RNAseq and scRNAseq) and metabolic and regulatory networks in clinically relevant pathogens.
Nikolaos Nikoloudakis
Dr. Nikolaos Nikoloudakis is an Assistant Professor at the Cyprus University of Technology (CUT). He graduated (2002) from the Agricultural Biotechnology Department of the Agricultural University of Athens (AUA) and has a MSc in the field of plant biotechnology (2005). He obtained his PhD at the Plant Breeding and Biometry Laboratory (AUA) caring out research involving phylogenetic relationships of Avena species and the study of intergenomic modifications using interspecific hybrids of different ploidy levels (2009). Furthermore, he was a post-doc researcher and a special teaching staff at the Department of Agricultural Sciences, Biotechnology and Food Science (ABF) of the Cyprus University of Technology (2017-2022). He has also served as a technical manager of the national reference laboratories of the Hellenic Ministry of Rural Development and Food, regarding GMO detection in seed lots and the control of pathogenic viruses in plant reproductive material (2011-2016). He has contributed to the formation of research networks as a partner from CUT in several national and European projects and participates in several funded research projects (Horizon 2020, Horizon Europe, Prima, RIF and ECPGR). His main research interests are agricultural biotechnology, plant genetic resources, genotyping, and flow cytometry.
Corey Nislow
Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
Fabio TS Nogueira
Associate professor of Plant Molecular Biology and coordinator of the graduate program Plant Cell and Molecular Biology, University of Sao Paulo, Brazil. President, Institutional Biosafety Committee, University of Sao Paulo; Past President, Environmental Ethics in Research Committee, University of Sao Paulo.
Barbara Nowak
Barbara is Professor at the University of Tasmania (UTAS), where she leads Aquatic Animal Health research group. Barbara has her PhD from Sydney University and has been working at UTAS since 1991. Her research interests focus on various aspects of fish health, such as fish parasitology, fish immunology and fish pathology. Barbara has published over 200 papers and supervised more than 30 PhD students. She has received awards for her research and supervision of PhD students.
Rodrigo Nunes-da-Fonseca
Associate Professor at the Center for Ecology and Socio-Environmental Development of Macaé, (NUPEM), Federal University of Rio de Janeiro (UFRJ-Macaé). Affiliate Member of the Brazilian Academy of Sciences (2017-2021). Scientist of Our State at FAPERJ (2019-nowadays), PhD (2008) and Postdoctoral studies (2009) in Functional Genomics and Evolutionary Developmental Biology (Evo-Devo) at the University of Cologne, Germany.
Published more than 85 articles in specialized journals with more than 3500 citations (Google Scholar-Fator H = 24). He serves as a reviewer for several international journals (NAR, Cell Reports, Dev. Gen Evol, Dev. Biol, FEBS J, Plos One, Gene, among others) particularly in the evolutionary genetics of arthropod development.
Olorunseun O Ogunwobi
Dr. Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, and a PhD in molecular biology from the University of East Anglia, Norwich, United Kingdom. He was the Founding Director of the Hunter College Center for Cancer Health Disparities Research. He is now the Barnett Rosenberg Professor of Biochemistry and Molecular Biology and Chairperson in the Department of Biochemistry and Molecular Biology at Michigan State University. In addition, he will serve as Co-Director of the forthcoming Center for Cancer Health Equity Research (CCHER) at Michigan State University. He is a translational cancer biologist whose work focuses on molecular mechanisms of progression of solid organ cancers with racial disparities, and on approaches to leverage non-coding RNA biology for potential clinical applications in cancer. His work has been funded by the National Institutes of Health, New York State, Carnegie Corporation of New York, and the National Science Foundation, among others. Dr. Ogunwobi was a Founding Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants CA221704 and CA221705 from the National Cancer Institute. An author of 74 peer-reviewed journal articles and 3 book chapters, Dr. Ogunwobi has been issued 5 US patents for biotechnology inventions with potential clinical applications in cancer. He is the recipient of the 2022 Hunter College Presidential Award for Excellence in Scholarship or Creative Activity, and selected as a Jefferson Science Fellow by the National Academies of Sciences, Engineering, and Medicine, and as a Fellow of the Academy of Medicine Specialties of Nigeria. He is Co-Founder of UTR Therapeutics, Inc (winner of the 2023 XSeed Award from Deerfield), and NucleoBio, Inc.
Sonia MR Oliveira
Doctor Sonia Oliveira holds a Licenciatura in Biology (pre-Bologna) and a Master in Cellular and Molecular Biology from the University of Aveiro, where she also specialized in medicinal plants, toxicology, murine models, and spermatogenesis. In 2011 she moved to Australia to work in Reproductive Biological Sciences. She later explored the nerve-cancer connection in Cancer, namely in female cancers, and completed her Ph.D. in Human Physiology ( with a significant component in Medical Biochemistry and Neurophysiology) from the University of Newcastle (Australia) in 2018. She then worked with biomimetic systems and nanotechnology in diabetes and stem cells. She explored multiple methods for primary and secondary cell culture, always with a keen interest in histopathology, cell biology, and rare disorders. Participated in >40 event(s). (Co-)Supervised MSc dissertation(s) and final projects for course completion of LSc/BSc. And works mostly in the area(s) of Natural sciences with emphasis on Molecular and Cellular Biology, and Medical and Health Sciences with emphasis on Neurosciences, Cancer, Reproduction, Toxicology, Biotechnology, and Stem cells. Also has collaborations in Microbiology, Biomaterials, and Communication and Information technologies.
Brenda Oppert
EDUCATION
University of Texas at El Paso (9/75-8/78), B.S. in Biology, 1978
University of Texas at El Paso (1/83-12/86), M.S. in Biology, 1986
Kansas State University (8/86-5/91), Ph.D. in Biochemistry, 1991
PROFESSIONAL
• Research Molecular Biologist (GS-15), CGAHR, Manhattan, KS (4/91-present)
• Adjunct Professor, Department of Entomology, Kansas State University (1/99-present)
Krishna Dev Oruganty
I can best describe myself as a simulation biologist. I am interested in simulating life processes at multiple scales. From the atomic scale to understand protein function to cellular or systems scale to understand physiological processes. My main tool is the computer which I use to analyze, understand and predict biology. Secondary tools are in vitro biochemistry and biophysics experiments that I use to validate my predictions.
Hilal Ozdag
Dr. Özdağ took her BSc in Biology from Hacettepe University Department of Biology on 1993. She then get her MSc degree in Biotechnology from the same department on 1995. Dr. Özdağ got her PhD on 2000 from Bilkent University Department of Molecular Biology and Genetics. Her PhD dissertation was on Hereditary Breast Cancer Genetics in Turkish Population. Dr. Özdağ then moved to UK for her postdoctoral studies. As a postdoctoral research associate at Prof. Caldas’s Laboratory in Cambridge University Hutchison-MRC Research Centre Dr. Özdağ worked on chromatin modifier genes in epithelial cancers.
Dr. Özdağ is leading her own research group at Ankara University Biotechnology Institute, Systems Biotechnology Advanced Research Unit (SISBIOTEK) since 2005. The team is conducting studies aiming to discover theranostic marker for colorectal cancer.
Luis G. C. Pacheco
Dr. Luis Pacheco is currently an Associate Professor of Biotechnology (Molecular Biology) at the Universidade Federal da Bahia (UFBA), in Salvador-BA, Brazil. During 2019, he has also been working as a Visiting Researcher at the Brigham and Women’s Hospital / Harvard Medical School, Boston-MA, USA. He received his 2010 PhD in Biochemistry and Molecular Biology from a leading university in Brazil, the Universidade Federal de Minas Gerais (UFMG), with an international split-site scholarship period (2008-2009) at the University of Warwick, in the United Kingdom. His research is focused on using functional genomics and synthetic biology approaches for development of novel genetic tools with broad applications in biotechnology, particularly in the fields of diagnostics of infectious diseases and therapeutics of inflammatory diseases.